236 related articles for article (PubMed ID: 35008517)
1. Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats.
Uttl L; Hložek T; Mareš P; Páleníček T; Kubová H
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008517
[TBL] [Abstract][Full Text] [Related]
2. Partial protective effects of cannabidiol against PTZ-induced acute seizures in female rats during the proestrus-estrus transition.
Janisset NRLL; Romariz SAA; Hashiguchi D; Quintella ML; Gimenes C; Yokoyama T; Filev R; Carlini E; Barbosa da Silva R; Faber J; Longo BM
Epilepsy Behav; 2022 Apr; 129():108615. PubMed ID: 35217387
[TBL] [Abstract][Full Text] [Related]
3. Preclinical efficacy of cannabidiol for the treatment of early-life seizures.
Witherspoon E; Quinlan S; Forcelli PA
Pharmacol Rep; 2022 Oct; 74(5):1092-1098. PubMed ID: 36220975
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).
Klein BD; Jacobson CA; Metcalf CS; Smith MD; Wilcox KS; Hampson AJ; Kehne JH
Neurochem Res; 2017 Jul; 42(7):1939-1948. PubMed ID: 28478594
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels.
Vilela LR; Lima IV; Kunsch ÉB; Pinto HPP; de Miranda AS; Vieira ÉLM; de Oliveira ACP; Moraes MFD; Teixeira AL; Moreira FA
Epilepsy Behav; 2017 Oct; 75():29-35. PubMed ID: 28821005
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models.
Patra PH; Barker-Haliski M; White HS; Whalley BJ; Glyn S; Sandhu H; Jones N; Bazelot M; Williams CM; McNeish AJ
Epilepsia; 2019 Feb; 60(2):303-314. PubMed ID: 30588604
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.
Jones NA; Glyn SE; Akiyama S; Hill TD; Hill AJ; Weston SE; Burnett MD; Yamasaki Y; Stephens GJ; Whalley BJ; Williams CM
Seizure; 2012 Jun; 21(5):344-52. PubMed ID: 22520455
[TBL] [Abstract][Full Text] [Related]
8. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ
Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol attenuates generalized tonic-clonic and suppresses limbic seizures in the genetically epilepsy-prone rats (GEPR-3) strain.
Lazarini-Lopes W; Campos-Rodriguez C; Garcia-Cairasco N; N'Gouemo P; Forcelli PA
Pharmacol Rep; 2023 Feb; 75(1):166-176. PubMed ID: 36195689
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.
Löscher W; Nolting B; Hönack D
Eur J Pharmacol; 1988 Jul; 152(1-2):9-17. PubMed ID: 3061831
[TBL] [Abstract][Full Text] [Related]
11. Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats.
Mares P; Mikulecká A
Epilepsy Behav; 2009 Jan; 14(1):32-9. PubMed ID: 18786655
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol effect in pentylenetetrazole-induced seizures depends on PI3K.
de Assis Lima IV; Pinto HPP; Bellozi PMQ; da Silva MCM; Vilela LR; Moreira FA; Moraes MFD; de Oliveira ACP
Pharmacol Rep; 2022 Oct; 74(5):1099-1106. PubMed ID: 36112318
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.
Jones NA; Hill AJ; Smith I; Bevan SA; Williams CM; Whalley BJ; Stephens GJ
J Pharmacol Exp Ther; 2010 Feb; 332(2):569-77. PubMed ID: 19906779
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.
Rodríguez-Muñoz M; Onetti Y; Cortés-Montero E; Garzón J; Sánchez-Blázquez P
Mol Brain; 2018 Sep; 11(1):51. PubMed ID: 30223868
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the FDA-approved cannabidiol on the development and persistence of temporal lobe epilepsy and complex focal onset seizures.
Reddy DS; Mbilinyi RH; Ramakrishnan S
Exp Neurol; 2023 Jan; 359():114240. PubMed ID: 36216124
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of sodium valproate loaded nanoparticles in acute and chronic pentylenetetrazole induced seizure models.
Meenu M; Reeta KH; Dinda AK; Kottarath SK; Gupta YK
Epilepsy Res; 2019 Dec; 158():106219. PubMed ID: 31726286
[TBL] [Abstract][Full Text] [Related]
17. The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights.
Lazarini-Lopes W; Do Val-da Silva RA; da Silva-Júnior RMP; Leite JP; Garcia-Cairasco N
Neurosci Biobehav Rev; 2020 Apr; 111():166-182. PubMed ID: 31954723
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures.
Funck VR; de Oliveira CV; Pereira LM; Rambo LM; Ribeiro LR; Royes LF; Ferreira J; Guerra GP; Furian AF; Oliveira MS; Mallmann CA; de Mello CF; Oliveira MS
Epilepsia; 2011 Nov; 52(11):2094-104. PubMed ID: 21906051
[TBL] [Abstract][Full Text] [Related]
19. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
20. The Potential Mechanism of Cannabidiol (CBD) Treatment of Epilepsy in Pentetrazol (PTZ) Kindling Mice Uncovered by Multi-Omics Analysis.
Lu H; Wang Q; Jiang X; Zhao Y; He M; Wei M
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
